Evestra Snags DoD Grant For Experimental Breast Cancer Drug Research

By David Holley, Xconomy San Antonio—A small Texas biotech that develops women’s health ...

Promising Treatment for Ebola Virus to be Tested at Texas Biomed

Ricardo Carrion, Jr., Ph.D. During the West African Ebola outbreak that began in 2013, an experimental ...

Two S.A. companies recognized
March 5, 2013

By Patrick Danner, San Antonio Express-News

Two San Antonio companies recently were selected as being among the "10 most promising life science companies" at the Texas Life Science Venture Forum in Houston.

The two are Aperion Biologics Inc., a clinical-stage medical device company that has developed and patented a technique to make animal tissues usable for human applications, and ViroXis Corp., which is developing drugs to treat skin diseases.

"San Antonio companies continue to demonstrate scientific innovation and compelling value," BioMed SA President Ann Stevens said in a statement.

The forum is the largest life science venture capital conference in the Southwest. Attendees included venture capitalists and other investors, entrepreneurs and industry representatives.

Read more:

NOTE FROM BIOMED SA: Another company with San Antonio roots, OtoMetrix Medical Technologies, was also recognized as one of the 10 Most Promising Life Science Companies at the Texas Life Science Venture Forum. OtoMetrix is commercializing an ultrasound medical device to rapidly and accurately diagnose middle ear infections.


Stay informed. Subscribe to BioMed SA news alerts.